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Abstract
T-cell development comprises a stepwise process of commitment from a multipotent precursor. To
define molecular mechanisms controlling this progression, we probed five stages spanning the
commitment process using RNA-seq and ChIP-seq to track genome-wide shifts in transcription,
cohorts of active transcription factor genes, histone modifications at diverse classes of cis-
regulatory elements, and binding repertoire of GATA-3 and PU.1, transcription factors with
complementary roles in T-cell development. The results highlight potential promoter-distal cis-
regulatory elements in play and reveal both activation sites and diverse mechanisms of repression
that silence genes used in alternative lineages. Histone marking is dynamic and reversible, and
while permissive marks anticipate, repressive marks often lag behind changes in transcription. In
vivo binding of PU.1 and GATA-3 relative to epigenetic marking reveals distinctive, factor-
specific rules for recruitment of these crucial transcription factors to different subsets of their
potential sites, dependent on dose and developmental context.
INTRODUCTION
T lymphocyte development illuminates the stepwise process of cell fate choice for
descendants of multipotent stem cells. Notch pathway signaling in the thymus causes
hematopoietic precursors to become committed to the T-cell fate, while mobilizing a T-cell
gene expression program that prepares the cells for T-cell antigen receptor (TCR)
expression, TCR-based repertoire selection, and long, versatile careers as immune effectors.
Sequential events that exclude alternative lineages occur at phenotypically well-defined
stages within the thymus, providing a revealing model for the kinds of events needed to
channel multipotent stem cells into a single developmental path (Rothenberg, 2011; Yang et
al., 2010). However, major questions about the molecular mechanisms involved in this
process have remained.
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One question is how commitment works. Regulatory genes that promote access to
alternative fates are either expressed or inducible in the precursors entering the thymus, but
end up not only repressed but irreversibly silenced as a result of commitment. The
mechanisms responsible for these regulatory changes have been unknown.
Another question has been how the T-cell program is deployed. Notch signaling initiates and
sustains differentiation. T-cell development also depends on additional transcription factors,
including E2A and HEB, TCF-1 and LEF-1, GATA-3, Myb, Runx1, Ikaros, and Gfi1 [rev.
in (Rothenberg et al., 2008)]. However, it is not clear if this list is complete, and how these
factors work remains murky because so few T-cell-specific cis-regulatory elements have
been identified. Almost none have been functionally dissected in enough detail to explain
fully the expression of the genes they control.
In other hematopoietic cell types, key cis-regulatory sequences of developmental genes have
been identified through the collaborative binding of factors known to confer cell-type
identity. For example, combined binding sites of E2A, EBF1, and/or Pax5 predict cis-
regulatory elements in developing B cells (Lin et al., 2010; Schebesta et al., 2007). In
contrast, no formula known a priori has been useful to define T-lineage specific cis-
regulatory elements. However, if all the cis-regulatory elements that are “in play” at crucial
transitions of T-cell development could be defined, then the motifs enriched in these
elements could be matched with the cognate transcription factors that also change at those
stages (Novershtern et al., 2011), thus narrowing the search for the key factors in
commitment.
Here we identify the dynamic transformations in transcription and epigenetic marking that
occur across the genome through five stages of T-cell differentiation that span lineage
commitment. The results provide a genome-wide view of a lineage choice process in
unusually fine resolution. To test the functional relevance of the histone marking patterns at
potential cis-regulatory elements, we also track in vivo binding of GATA-3 and PU.1, two
transcription factors with complementary roles in early T-cell development (Rothenberg and
Scripture-Adams, 2008). Recruitment rules for these two factors are revealed to be context-
dependent but differently affected by dose. The results also reveal how an initial regulatory
phase dominated by stem/progenitor-cell regulatory genes first overlaps with Notch
signaling, then is dismantled to establish T-cell identity.
RESULTS
Capturing commitment
Our goals were first, to map comprehensively the genes that undergo transcriptional change
during T-lineage choice, especially genes encoding transcription factors; and second, to
locate likely cis-regulatory sites mediating these gene expression changes by defining
regions where histone marks are altered at each step of the process.
Cells in the first major stage of T-cell development, “early T-cell precursors” or Kit++ DN1
cells, pass through the DN2a stage to the DN2b stage, when they undergo T-lineage
commitment. Post-commitment, they accumulate in the DN3 stage, during which they
rearrange the TCR genes. Only cells that successfully express TCR proteins ever proliferate
again, differentiating to the DP stage in a process called “β-selection” [rev. in (Rothenberg
et al., 2008)]. Cells are selected after this based on their TCR recognition specificity, and
further differentiation refines their mature immunological roles.
To obtain enough of the earliest cells for genomic analysis, we used an in vitro
differentiation system that generates copious yields of early T-cell precursors from fetal
Zhang et al. Page 2
Cell. Author manuscript; available in PMC 2013 April 13.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
liver-derived (FL) hematopoietic progenitor cells. These precursors are co-cultured with
lymphoid-permissive cytokines and OP9 stromal cells expressing a Delta-like Notch ligand
(OP9-DL1). In these conditions a cohort of FLDN1 and FLDN2a cells is generated by day
4.5 of culture, mostly progressing to FLDN2b cells by day 8.5 (Fig. S1A). For an in vivo
counterpart, we purified slightly more advanced DN3 stage cells from freshly isolated adult
mouse thymus, and to show the effects of β-selection, DP thymocytes were also purified
(ThyDN3, ThyDP)(Fig. S1B, C, see Supplemental Methods).
In vitro differentiated FL-derived DN1 and DN2 cells showed gene expression well matched
to that of normal in vivo thymocyte counterparts [(Yui et al., 2010; David-Fung et al.,
2009)][http://www.immgen.org (Heng et al., 2008)]. Their lineage commitment status was
also in good agreement with that of in vivo counterparts (Rothenberg, 2011; Yui et al.,
2010), as shown by shifting cells to non-T conditions (Table S1), despite some minor
differences (Table S1 legend). As in adult thymus in vivo, cells became committed from
DN2a to DN2b.
Global gene expression analysis: selective changes during early T-cell development
We used RNA-seq (Mortazavi et al., 2008) to identify when major changes in gene
expression occurred along the pathway from early T-cell precursor to DP stages, using 2–3
independent biological replicates each of FLDN1, FLDN2a, FLDN2b, ThyDN3, and ThyDP
cells (Pearson r>0.97 for independent replicates of the same stages, Fig. S1D). About 10,000
of the 20,861 Refseq genes were detectably expressed (≥ 1RPKM) in each population; of
these, ~50% changed significantly in expression (p< 0.001) between at least one pair of
stages and ~ 40% changed from FLDN1 to ThyDP (Fig. 1A).
Fig. 1B shows hierarchical clustering of the expression patterns of the 3,697 genes that
change expression ≥2× between any stages. Between DN1 and DN2b key T-cell specific
genes involved in pre-TCR expression and function were induced from a low or
undetectable level (Table S2), i.e. genes encoding TCR complex components Cd3g, Cd3d,
Cd3e, Cd3z (Cd247), T-cell-specific signaling components Itk and Lat, recombinase Rag1,
mutagenic DNA polymerase Dntt, and the surrogate α chain (pTα) Ptcra. In addition, a
conspicuous group of genes were repressed or silenced during these transitions. They
included progenitor-cell specific growth factor receptor genes Kit, Flt3, and Csf2rb, and a
set of transcription factor genes described below.
The DN1 to DN2 transition is the first definitive sign of T-lineage entry induced by Notch
signaling. However, a much larger difference was seen between pre-commitment FLDN2a
and post-commitment FLDN2b cells (2429 genes different, Fig. 1A, B) than between
FLDN1 and FLDN2a (<900 genes different), also seen by hierarchical clustering.
Conversely, despite their different origins and manipulation, the newly-committed FLDN2b
and ThyDN3 populations were more similar to each other as well (Fig. 1A, B). Thus, the
major genome-wide transcriptomic changes leading to T-lineage identity do not occur in the
DN1 to DN2a transition, but rather in transition to the DN2b or DN3 stages, linked with
commitment.
Transcription factor expression dynamics in T-lineage commitment
Genes likely to encode transcriptional regulators (Table 3A, see Supplemental Methods)
included 379 that changed expression by ≥2× (Table S3B). Hierarchical clustering of their
patterns of expression (Fig. 1C) again showed similarities between FLDN1 and FLDN2a
and between FLDN2b and ThyDN3, while the precommitment FLDN2a cells were more
different from the newly committed FLDN2b (Fig. 1C); the ThyDP cells were the most
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different from all. Thus, the two major transitions in regulatory gene expression occur at
commitment and at β-selection.
From FLDN1 to FDN2b, the most strongly upregulated “regulatory” loci in the whole
genome were found to be Lef1 and Bcl11b (>75× increased). Pou6f1, SpiB, Ikzf3, and Ets1
among others also increased >8×, with weaker increases for Id3, Tcf12, Gfi1, Tcf7, Hes1,
and Gata3 (Table S3B). However, many regulatory genes sharply decreased in expression
between FLDN1 and FLDN2b, including genes with known, important functions in
hematopoietic progenitors, e.g. Gfi1b, Lmo2, Mef2c, Hoxa9, Sfpi1 (PU.1), Gata2, Mycn (N-
Myc), Cebpb, Bcl11a, Hhex, Nfe2, Lyl1, and several Irf factors. A major regulatory shift,
with broad repression of progenitor-cell transcription factor genes, thus accompanies T-
lineage commitment.
Dynamic histone modification changes identify developmentally regulated promoters and
distal cis-elements
The specific cis-regulatory elements affected by changing transcription factor action during
commitment should be sites of developmentally changing histone modifications [rev. by
(Natoli, 2010; Kouzarides, 2007)], of greatest interest where they are linked to differentially
expressed genes. We used chromatin immune precipitation and deep sequencing (ChIP-seq)
(Johnson et al., 2007)(Barski et al., 2007) to enrich DNA associated with three H3
modifications: H3K(9,14)Ac, H3K4me2, and H3K27me3. Histone H3K(9, 14) acetylation
(H3Ac) is functionally linked to activation at transcriptional start sites (TSS), H3K27me3 is
used in one mechanism for transcriptional silencing, and H3K4me2 is associated with
activation, poising for activation or repression, or repression (Orford et al., 2008; Barski et
al., 2007; Johnson et al., 2007; Heintzman et al., 2007). For many enhancers, H3K4me2
provides more precise localization than H3K4me1 (Koche et al., 2011). The results from
independent biological replicates again showed excellent correlation (Fig. S1E).
The 42,000 regions with marks were distributed near and distal to the annotated TSS of
expressed and silent genes (Fig. 2A, Fig. S2B); tables S2A (TSS) and S2B (non-TSS) report
intensities of marking at each stage as correlated with RNA expression of the nearest genes.
Fig. S3 presents these comprehensive results for TSS and non-TSS sites for all Refseq loci
in hierarchically clustered heat maps.
Consistent with previous reports, H3Ac and H3K4me2 were overwhelmingly seen at
promoters of expressed genes. Silent genes fell into two classes, with only ~35% showing
H3K27me3 at their promoters. H3K27me3 was more common at silent regulatory genes
than at other silent loci (Fig. 2A,B right panels). However, >25% of the silent genes,
including many with H3K27me3, were also marked with H3K4me2 (Figs. S2C,S3),
consistent with at least three kinds of repressed states (Filion et al., 2010). The cumulative
frequency plots in Fig. 2C show that genes with H3K4me2 but not H3Ac at their promoters
in a given stage (red tracks) (±H3K27me3) were most likely to be newly repressed or poised
for upregulation in the next stage. Thus, H3K4me2 without H3Ac marks developmentally
labile promoters (Koche et al., 2011; Orford et al., 2008).
Histone modification at promoters was relatively stable across development, more than
levels of corresponding RNAs (Fig. S3A). However, distal elements were more dynamically
marked: >1/3 of all regions marked with H3K4me2 or H3K27me3 in one stage lacked those
marks in at least one other stage (Fig. S3B). Thus regulatory shifts occurring in development
most sensitively affect histone marking at non-promoter elements (Heinz et al., 2010; Lin et
al., 2010). H3K4me2-marked distal elements in fact included a number of previously noted
regulatory elements (Fig. S4A,B): the DP-specific Rag1–Rag2 gene antisilencer 71–75kb 5’
of the Rag2 gene (Yannoutsos et al., 2004), and the DN2b/3-specific E1a promoter for the
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Notch1 gene (Gomez-del Arco et al., 2010). Both of these discrete cis-elements acquired
H3K4me2 specifically at stages when they contribute to gene regulation (Fig. S4A,B). Other
non-TSS regions with developmentally dynamic marking may thus locate stage-specific cis-
regulatory elements as well.
Timing of TSS epigenetic changes relative to transcriptional changes
To relate the timing of changes in TSS marks with changes in RNA expression during T-cell
commitment, we focused on 3,697 differentially regulated genes. First, these were
subdivided by K-means clustering into 25 clusters based on expression pattern (Fig. S5;
genes listed in Table S4A). Fig. 2D tracks histone marks from stage to stage at the TSS of
genes undergoing upregulation (clusters 1, 2, 6), downregulation (clusters 7, 9, 23), and
transient decreases (cluster 12) or increases in expression (clusters 17, 19). H3Ac
modification (Fig. 2D, first group of columns) was tightly coordinated with presence of
RNA (last columns), but H3K4me2 was often present before and after expression (second
columns, e.g. clusters 1 & 6). Though H3K27me3 was inversely correlated with expression,
only a fraction of repressed genes ever acquired this mark (Fig. 2D, third columns), as also
seen at promoters genome wide (Fig. S3A).
Most relevant to the regulatory decisions in T-lineage commitment (Rothenberg, 2011;
Yang et al., 2010) are effects on genes needed for other hematopoietic cell fates, options
which are shed in an ordered process. We identified 389 key hematopoietic genes by Gene
Ontology (Table S4B), including “signature” regulators of erythroid cells (Gata1, Nfe2,
Epor), myeloid cells (Sfpi1, Cebpa, Cebpe, Csf1r), B cells (Pax5, Ebf1), NK cells (Eomes,
Il2rb), and stem cells (Gata2, Tal1, Lmo2), and tracked their expression from DN1 to DP in
parallel with the status of histone marks at their promoters (Fig. 3). Full results are shown in
Table S4B and the Fig. 3 master panel, while zoom-in panels allow individual genes to be
identified. Again, H3Ac modification at promoters was tightly correlated with transcription,
while H3K4me2 marking also preceded and persisted after transcription.
To explain alternative-lineage exclusion in T-cell commitment, either one or diverse
mechanisms of silencing of non-T regulatory genes might be used. In fact, H3K27me3 use
at these functionally relevant loci was both variable and dynamic. Some genes were silent
throughout T-cell specification, and many had strong H3K27me3 marks at the promoter,
either apparently with H3K4me2 (e.g. Group e, Epor, Irf4, Ebf1, and Eomes) or without
(e.g. Group e, Pax5). Other regulatory genes were turned off during development, often
gaining H3K27me3 while they lost H3Ac (Group d). Some genes poised for early silencing
already had some H3K27me3 at the TSS from FLDN1 stage (e.g. Cebpa in Group e, Gata2,
Lmo1, Tal1 in Group d), suggesting repression already underway in at least part of the
population. However, H3K27me3 did not mandate future silencing, for some T-cell genes
like Lef1 were strongly activated during commitment despite initially strong H3K27me3
marking (Group b). Furthermore, other genes stayed silent from FLDN1 to ThyDP without
any H3K27me3 at the TSS (e.g. Cebpe, Cx3cr1, Zbtb32, Cd79a, and VpreB1; Group c).
Unexpectedly, these variations in H3K27me3 marking cut across myeloid, erythroid, NK
cell, and B-cell program boundaries.
Most epigenetic change in T-cell development occurs from DN1 to DP
Both the foreshadowing of future expression by H3K4me2 marking of promoters and the
ability of some genes to be repressed without appearance of H3K27me3 (Figs. 2D, 3) raised
the question of whether we might be missing changes in promoter status either before DN1,
or after DP stage. We therefore compared our results with H3Ac, H3K4me2, and
H3K27me3 ChIP-seq data for a prethymic lymphoid precursor population, “PPB” [EBF−/−
pre-pro B cells (Lin et al., 2010; Heinz et al., 2010)] and H3K27me3 data for post-thymic
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naïve CD4 T cells, “CD4” (Wei et al., 2009), shown in flanking columns in Figs. 2D and 3.
The prethymic lymphoid precursor data in general concurred with the FLDN1 patterns for
all three histone marks. Furthermore, repressed genes that lacked H3K27me3 marks by the
DP stage in our samples also remained silent without H3K27me3 marks in the mature T
cells (the uniquely regulated Rag genes were an exception). The FLDN1 to ThyDP interval
thus encompasses the crucial epigenetic changes for the great majority of genes affected by
T-cell specification.
Distinct mechanisms control key developmental genes
Changes in modification at distal sites (compiled in Table S2B) as well as TSS sites (Table
S2A) often appeared implicated in gene regulation, as shown for key genes in Fig. 4. Fig.
4A, B profile two highly T-cell-specific loci activated in parallel from DN2a to DN2b, the
Cd3gde gene cluster (A) and Bcl11b (B). These genes initially lack RNA transcripts (black
tracks) and H3Ac marks (blue tracks) in FLDN1 cells, but then are strongly upregulated and
kept on thereafter.
For the Cd3 genes, there was no H3K4me2 (red tracks) at the promoters and light
H3K27me3 marking across the locus (Fig. 4A, green tracks) during the initial silence, but
the classic enhancer elements at the 3’ ends of Cd3e and Cd3d (Georgopoulos et al., 1988;
van de Wetering et al., 1991) were already marked by focal H3K4me2. These enhancers
were already accessible to transcription factor binding even in the FLDN1 stage, as shown
by binding of the factor GATA-3 (Fig. S4C; see below). Marking of these H3K4me2 sites
intensified while H3Ac and H3K4me2 were recruited to the promoters of the genes during
the DN2a/2b stages, when transcription began. A similar pattern for activation without
initial promoter marking was seen for Il2ra (Fig. S4D).
In contrast to the Cd3gde cluster, the Bcl11b gene (Fig. 4B) began with substantial
H3K27me3 (green tracks) over its promoter and the whole gene body at FLDN1 stage.
However, its TSS had a cryptic positive cis-regulatory element marked by H3K4me2.
Bcl11b then was activated from FLDN2a to FLDN2b stage through a process that swept
back the H3K27me3 repressive marks off the promoter, while expanding the H3K4me2
marks into the first intron and creating a new H3K4me2 marked region in the third intron.
The changes in histone marks at these loci contrast with the precisely positioned but
virtually unchanging H3K27me3, H3Ac, and H3K4me2 marks that characterized the Gata3
gene (Fig. 4C). Despite a block of H3K27me3 close to the major promoter, this gene was
already activated by the time of the FLDN1 stage, and underwent only a fewfold increase in
expression after that.
Repression of essential B-cell regulatory factors, myeloid-cell regulatory factors, and stem
or progenitor-cell regulatory factors is central to T-lineage commitment. This clearly
entailed a variety of distinct mechanisms (Fig. 4D–H). The Pax5 gene, crucial for the B-cell
program, had no H3Ac modified regions at any stages (Fig. 4D; cf. neighboring Zcchc7 TSS
mark). Small peaks of H3K4me2 marking were seen in intronic regions, one of them
corresponding to a known hematopoietic enhancer (Decker et al., 2009). However, the gene
was buried in H3K27me3 at all stages. Ebf1 (Fig. S4E) was also repressed from FLDN1 on
despite H3K4me2 at several sites.
Hhex and Bcl11a (Fig. 4E, F), in contrast, were expressed strongly in FLDN1 cells but then
downregulated sharply by the FLDN2b/ThyDN3 stages, showing evidence of distinct
modulating roles for distal and TSS elements. For Hhex (Fig. 4E), the TSS and two
H3K4me2-marked distal regions lost activation marks as expression decreased, while
H3K27me3 appeared focally at the TSS and then spread. A similar pattern was seen for Flt3
Zhang et al. Page 6
Cell. Author manuscript; available in PMC 2013 April 13.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
and the Zbtb7b (Thpok) gene, both active in FLDN1 and then repressed (Fig. S4F,I). For
Bcl11a (Fig. 4F), H3Ac persisted at the promoter while RNA expression declined during
commitment, reflecting a tail of low-level expression through DN3. H3K27me3 marks only
appeared at the last stage of silencing in the DP stage. However, the H3K4me2 modification
just downstream of the last exon decreased sharply between FLDN2a and FLDN2b, in
parallel with RNA expression, suggesting a potential regulatory role for a distal element
here.
The myeloid and progenitor-cell transcription factor gene Sfpi1 (encoding PU.1), silenced in
parallel with Hhex and never re-expressed in most T-cell lineages, used a different
mechanism of repression (Fig. 4G). H3Ac disappeared from the promoter while H3K4me2
marks in the upstream cis-regulatory elements of the gene (Rosenbauer et al., 2006;
Zarnegar et al., 2010) narrowed as transcription declined (Fig. 4G). Yet minimal H3K27me3
was ever seen.
Not only were H3K27me3 marks dispensable for repression; they were also labile. Fig. 4H
shows that dense H3K27me3 marks on Mpzl2 (same as Eva1) diminished during a spike of
RNA expression in the DN2b and DN3 stages, then returned during re-silencing in DP stage.
Conversely, despite silencing during commitment, Zbtb7b (Fig. S4I) is later activated for
CD4+ cell positive selection.
Early T-cell specific sites for PU.1: a positive role
The significance of epigenetic marks depends on their impact on transcription factor access
and their own emplacement via transcription factor binding. We therefore correlated
chromatin marks with binding of GATA-3 and PU.1 (encoded by Sfpi1), two factors needed
for early T-cell development, which play contrasting roles in the context of Notch signals
[rev. by (Rothenberg and Scripture-Adams, 2008; Hosoya et al., 2010)]. PU.1 is one of the
progenitor-associated transcription factors in early pro-T cells, but is even more critical for
B, dendritic and myeloid cell development. A key question is whether it has distinct T-
lineage target genes or simply carries over a multipotent state.
PU.1 bound to ~34,000 sites in DN T cells, comparable to B and myeloid cells (Heinz et al.,
2010). Although PU.1 RNA and protein levels decline sharply during T lineage commitment
(Fig. 5A)(Yui et al., 2010), PU.1 site binding preferences remained consistent from stage to
stage. We compared FLDN1 and FLDN2a cells; FLDN2b cells, where PU.1 is 4–5×
downregulated; and DP cells, where PU.1 is absent. Although PU.1 binding intensity per site
was ~4–5× lower in the FLDN2b cells, its site choices remained correlated with those in the
earlier stages (r=0.65–0.66)(Fig. 5B).
Even so, the PU.1 binding sites in FLDN1 and FLDN2a cells were distinct from those
reported in B cells, macrophages or even E2A−/− pre-pro B cells [representing prethymic
lymphoid progenitors (Heinz et al., 2010)](Fig. 5C). Although the sites bound in the pre-pro
B cells were most related, key PU.1 target sites occupied in pre-pro B cells were not bound
by PU.1 in FLDN1 cells, e.g. the intronic enhancer of Pax5 (Fig. 5D). De novo motif
analysis showed that PU.1 target sites in FLDN1 cells had a different hierarchy of preferred
sequences than in pre-pro B cells (Fig. 5E). Thus, the consistent site choices of PU.1 from
DN1 stage through commitment include a distinct T lineage-specific component.
PU.1 is needed to generate T-cell precursors, but at high levels it inhibits expression of
many T-cell specific genes, particularly if Notch signaling is interrupted (Franco et al.,
2006). To test whether the T-lineage specific sites of PU.1 may be repressive, delaying T-
cell gene activation in early stages, we asked whether PU.1 binding specific to early T cells
was linked to genes that are active or silent, as compared with sites bound by PU.1 in pre-
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pro B cells but empty in T cells. In fact, the sites occupied by PU.1 in FLDN1 cells,
including FLDN1-specific sites, were mostly associated with “positive” marks (H3Ac and/or
H3K4me2) and completely uncorrelated with H3K27me3 marking, more than sites bound
by PU.1 only in E2A−/− pre-pro B cells (Fig. 5F). In the aggregate, genes with sites of PU.1
binding in FLDN1 cells were also more likely to show strong expression, with higher
expression the more sites bound, including T-lineage specific sites (Fig. 5G). Thus, PU.1
binding globally correlates with target gene expression in FLDN1 cells.
PU.1 binding dynamics and temporal control of target gene expression
Experimental perturbation analyses have shown many specific genes in pro-T cells that are
activated or repressed by manipulations of PU.1 level (Franco et al., 2006)(A. Champhekar,
M. M. Del Real, and E. V. R., unpublished data). However, with so many binding sites for
PU.1, binding alone clearly could not define genes that depend on PU.1 for positive or
negative regulation. Most PU.1 binding sites were linked to genes expressed stably in all
stages whether PU.1 is present or not, like the majority of genes expressed in T-cell
development overall. PU.1 could thus be opportunistically recruited to many active genes
where it has no required role. To define properties of likely functional sites, we used the
dynamics of PU.1 expression itself to filter the binding sites identified genome-wide.
Because PU.1 expression declines, functionally important PU.1 sites should be enriched
near genes which themselves change in RNA expression, up or down, during development
as a function of PU.1 binding. We therefore compared changes in local PU.1 occupancy
from FLDN1 to FLDN2b (Fig. 6A) with the direction and magnitude of changes in RNA
expression of the linked genes, in two complementary ways. First, focusing only on the PU.
1 site-linked genes that change expression from DN1 to DN2b (Fig. 6B), we grouped them
according to whether their linked sites all lost PU.1 occupancy faster (Fig. 6B–C, blue) or
slower (red) than the global ~4× average decrease (green=genes with both kinds of sites).
Cumulative frequency plots were used to test if changes in PU.1 occupancy predicted the
direction of changes in gene expression (Fig. 6C), i.e., whether genes losing PU.1 first all
turn off like PU.1 itself, or become activated as PU.1 repression might be relieved. Such
analyses could detect both activated and repressed subgroups within a group as well as
general trends. However, genes which lost PU.1 binding most rapidly (blue curve) were
uniformly more downregulated and less upregulated than those with mixed sites.
Conversely, almost 80% of genes with sites that retained PU.1 best (red curve) increased
their expression from FLDN1 to FLDN2b.
Second, reciprocally, we classified individual PU.1 sites according to whether their linked
genes were upregulated, downregulated, stably expressed, or silent across the DN1 to DN2b
interval, and then assessed whether these sites near developmentally regulated genes tended
to lose PU.1 faster or slower than open but nonregulated sites, i.e. those linked to stably
expressed genes (Fig. S6A). Downregulated, upregulated, and stably expressed genes
relinquished their PU.1 binding very differently, and sites linked to upregulated genes
retained their PU.1 even better than fully “accessible”, stably expressed ones, again arguing
against a repressive role.
At candidate target genes identified both by co-regulation with PU.1 and by PU.1
perturbation effects, PU.1 typically occupied multiple regions, implying that full PU.1
regulatory function is commonly mediated through combinations of binding complexes. At
Tal1, both PU.1 binding and local H3K4me2 were lost jointly from three regions, as
transcription also declined (Fig. 6D). At the TSS and intragenic regions, PU.1 loss appeared
to open the way for H3K27me3 deposition. Similar patterns were seen at the TSS of the
known PU.1 target Flt3, and at a downstream element and a known intronic enhancer of
Hhex (Donaldson et al., 2005)(Fig. S4F, G). Other genes with binding sites that lose PU.1
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early include Lmo1 and Bcl11a as well as Itgam, which decrease naturally from FLDN1 to
FLDN2b; all are sharply downregulated in FLDN2 cells if Sfpi1 is deleted (not shown; A.
Champhekar and E. V. R., unpublished). A PU.1 target with a different pattern of expression
but a similar relation to PU.1 binding was Il7r, which is upregulated from FLDN1 to
FLDN2b. Despite the decreasing level of PU.1 protein, the Il7r gene retained PU.1 through
the FLDN2b stage, both at a known TSS positive regulatory site (DeKoter et al., 2002; Xue
et al., 2004), and at another putative cis-element within a silent neighboring gene, Capsl
(Fig. 6E). Here too PU.1 regions have a positive link to expression, even for this gene
integral for the T-cell program.
Histone marking and modes of action
PU.1 binding can recruit histone methyltransferases and create locally “open” chromatin
states (Ghisletti et al., 2010; Heinz et al., 2010), and in early T-lineage cells as in non-T
cells, PU.1 occupancy was dynamically linked with local H3K4me2 modification. Due to
the developmental stability of H3K4me2 modification at TSS’s, the association was clearest
at distal PU.1 binding regions, where H3K4me2 modification usually melted away as PU.1
binding decreased (Figs. S6B, bottom & S6D). In contrast to H3K4me2, PU.1 binding had
little overlap with H3K27me3, even at silent genes (Fig. S6C1, 2; S6D). PU.1 binding-
linked H3K4me2 was not simply an effect of general “accessibility” or expression level of
the linked gene (Fig. S6D, “silent” vs. “E2A−/−” sites). Thus, PU.1 occupancy-linked
changes in H3K4me2 could be used to screen candidate distal cis-regulatory regions with
PU.1-dependent activity.
Globally, with or without distal binding sites, PU.1 binding near the TSS appeared most
tightly correlated with a positive role (Fig. 6F). Genes from diverse expression pattern
clusters (see Figs. 2D, S5) could all harbor PU.1 binding either within the body of the gene
or in flanking regions, but differed sharply in frequencies of genes with PU.1 binding at the
TSS (Fig. 6G; Table S6). Genes coregulated with PU.1 itself (cl. 7; also 3, 9 & 23; blue
bars) were more likely to have PU.1 binding at the TSS than genes regulated divergently
from it (e.g. cl. 1, 2, 6; red bars)(Table S6B). In contrast, many T-cell genes that can be
downregulated by high-level PU.1 (Franco et al., 2006) either had no PU.1 binding in early
T cells or had binding only in the body or flanking regions of the genes. Genes with
particularly low expression in DN1 stage were most impoverished for PU.1 binding at the
TSS (Table S6A, χ2 test p <0.0001). Thus, PU.1 binding at the promoter may provide, or
indicate, specific antisilencing functions that maintain key stem- and progenitor-cell genes
in early FLDN1 and FLDN2a stages.
Developmentally plastic deployment of GATA-3 binding
GATA-3 is needed repeatedly in T-cell stages from ETP/DN1 onward and is crucial for T
lineage commitment, but capable of paradoxical effects at high doses (Taghon et al., 2007).
Unlike PU.1, it is expressed almost stably across all the stages analyzed (Fig. 4C; and
unpublished results). We therefore asked whether it controls the same targets in the distinct
regulatory states of FLDN1, FLDN2b, and ThyDP cells.
GATA-3 detectably bound only ~1500 regions (Table S7). In accord with its recurrent T-cell
roles, these GATA-3 sites were enriched for cis-elements of T-lineage genes including
Cd3d, Tcf7, Zbtb7b, and the DP-specific Rag1-Rag2 distal enhancer (Fig. S4C,H,I,B).
Occupancy patterns in our ThyDP samples were broadly consistent with those in DP CD3lo
samples published elsewhere (Wei et al., 2011)(r=0.60; Fig. S7A). Yet progenitor-specific
genes like Lyl1 and Erg (Fig. 7A,B) as well as later-expressed T-cell genes like Ets2 and Itk
(Fig. 7C,D) also harbored GATA-3 sites.
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Changes in GATA-3 binding were strongly positively correlated with expression trajectories
of linked genes both from DN1 to DN2b and from DN2b to DP (Fig. 7E), and also
correlated with H3K4me2 modification changes (Fig. 7F). GATA-3 binding was even more
likely to be a site of H3K4me2 enrichment than PU.1 binding (Fig. S7B). Yet GATA-3 also
bound regions linked to silent and active genes alike at early stages, and dramatically
differed from PU.1 in its ability to bind regions with H3K27me3 (Fig. S7C). For example, it
remained bound to Zbtb7b even as it became silenced with H3K27me3 (Fig. S4I).
Intriguingly, GATA-3 occupancy also preceded full cis-element activation for Cd3d and the
Rag enhancer (Fig. S4B,C), suggesting a possible “pioneering” role.
Most unlike PU.1, the distribution of GATA-3 occupancies among different regions was
strikingly different in FLDN1, FLDN2b, and ThyDP. This was despite nearly constant
protein availability, as shown by similar global occupancy levels and peak heights at stably
occupied sites such as the Tcf3 (Tcfe2a) promoter (Fig. 7D) and the Tcrb 3’ enhancer (not
shown) in all stages. The most common motifs at regions of occupancy were a classic
GATA site and an Ets family-like site (Fig. 7G), in FLDN1, FLDN2b, and ThyDP alike. But
from FLDN1 to ThyDP, GATA-3 occupancy increased sharply in some regions (e.g. Ets2 in
DN2b, Itk promoter in DP; Fig. 7B,C), while disappearing from others entirely (e.g. Lyl1,
Erg, Itk introns; Fig. 7A–C). Overall, whereas regions occupied in FLDN1 and FLDN2b
stages were moderately well correlated (Pearson r=0.61), sites in FLDN2b and ThyDP were
poorly correlated and those in FLDN1 and ThyDP entirely uncorrelated (r=−0.0064, Fig.
7H).
These results locate elements in T and non-T genes where the crucial T-cell factor GATA-3
can be contributing to regulation, from the FLDN1 stage on (Table S7). Nevertheless, they
also reveal that a target gene for GATA-3 at one stage of T-cell development may not
normally receive input from GATA-3 at another stage, despite similar GATA-3 availability.
In contrast to PU.1, GATA-3’s physiological deployment at any given stage depends not
only on its own availability but also on a specific developmental regulatory context.
DISCUSSION
Our results provide a resource for T cell development, a new reference case for regulatory
epigenomics, and potentially powerful new explanatory elements for a complex
developmental process. Our global, base-resolution timecourse of chromatin and
transcriptome changes sheds new light on the finely defined stages of T-cell specification.
The RNA-seq data not only quantify RNA levels but also provide detailed information about
promoter and exon choice that may affect gene regulation as well as function. Note that
these data also reveal noncoding transcripts that may be important in various regulatory
roles. Here, we focused on the ~400 regulatory gene loci that themselves are
developmentally regulated during this process, and also the subset of candidate cis-
regulatory genomic sites that undergo developmental changes in histone modifications,
revealing changes in local regulatory inputs. These are the most likely trans and cis
components of nodes in the gene network that causally drive successive steps of the T-cell
program.
Most powerfully, the results reveal the subcomponent processes out of which T-cell
specification is built. Relatively few regulatory genes are strongly activated during lineage
commitment itself, and the list is now likely to be complete. Furthermore, a major feature of
commitment is specific, marked downregulation of progenitor-cell genes, through an
unexpectedly complex process. Many important non-T hematopoietic regulatory genes are
still expressed in the precursors we examine through 4 days of consistent Notch pathway
signaling, and many persist even into the DN2a stage before they are shut off. Importantly,
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the histone marking status of the promoters and linked cis-elements provides an independent
line of evidence about the timing and mechanism of regulatory changes. Loss of H3Ac rules
out an artifact of the decay kinetics of old mRNA persisting after transcription has ceased.
Our results also show that the repression of progenitor-cell genes is not due to a single
switch. The diverse histone mark transformations that are applied to different repression
targets imply that a variety of biochemically and temporally distinct silencing mechanisms
must be used. Notably, this rules out Notch signaling itself as a common mechanism of
repression and implies that the T-lineage program requires multiple distinct repressor
functions to establish T-cell identity.
Dynamically regulated transcriptional repression during this process is often separable from
“epigenetic silencing”. Repeatedly, deposition of H3K27me3 histone marks follows RNA
downregulation, more likely as an effect and stabilizer of repression than an initial cause of
repression. De novo H3K27me3 marking appears in two distinct, major patterns. One can be
by lateral invasion from a neighboring patch of pre-existing “closed” chromatin, another is
by tight focal deposition at a previously active TSS or enhancer, followed by spreading. In
other cases repression does not involve H3K27me3 at all, possibly due to the nature of the
repressor: e.g. at Sfpi1 and Cd4, two key genes known to be repressed by Runx factors in
DN3 cells. Even when H3K27me3 is used, it is readily and precisely reversible. Repression
via DNA methylation was not studied here but is also reversible, as shown recently by the
cell type-specific demethylation of CpGs in DN2–DN3 cells at loci that include Tcf7 and
Bcl11b (Ji et al., 2010)(http://charm.jhmi.edu/hsc/). These examples show that
transcriptional repressors must act first to trigger chromatin closing, while transcriptional
activators retain power to undo it.
Our results also shed light on the positive regulation of the T-cell program. Despite known
essential roles, finding specific cis-regulatory targets for Notch, GATA-3, and TCF-1 has
been slow. The identification of a battery of cis-regulatory elements activated de novo from
DN1 to DN2b is an important new resource for clarifying these links. GATA-3 effects in
early T cells have been especially difficult to dissect, in part due to the profound loss of
viability when GATA-3 dose is reduced (Hosoya et al., 2009), and in part due to lineage-
inappropriate effects of GATA-3 in gain of function experiments (Taghon et al., 2007).
Identification of potential GATA-3 regulatory inputs into Tcf7 as well as Tcfe2a from the
earliest stages suggests a new level of regulatory interlinkage, which could explain the
acuteness of the GATA-3 requirement. At least in DP cells, data from (Wei et al., 2011)
suggest that the GATA-3 sites we see positively regulate Tcf7, Cd3d, and Zfpm1, and may
negatively regulate Tcfe2a. Our results may also help to explain GATA-3’s lineage
infidelity in gain of function experiments by showing that its recruitment to legitimate target
sites, even at a constant level of expression, is intensely stage specific. Altered dosages
could thus override the mechanisms that must provide appropriate targeting specificity.
The ordered alternative lineage exclusion events in T-lineage commitment are an ideal
context to test whether developmental relatedness is preserved in a hierarchy of epigenetic
chromatin changes. Clearly, separable events mediate repression of different alternative
lineages. The B-cell regulatory genes Pax5 and Ebf1 are silenced by H3K27me3 and
rendered inaccessible to PU.1 binding from the start, whereas the myeloid regulatory gene
Cebpa is bivalently marked. The myeloid and progenitor regulatory gene Sfpi1 (PU.1),
initially fully activated, appears to play a regulatory role even into the DN2b stage, and is
silenced only when T-cell gene expression is under way. However, there is no simple
mapping of developmental lineage exclusion order with a particular molecular class of
repression mechanism. Drivers of the most “distant” fate in developmental terms, the
erythroid genes, can be repressed via H3K27me3 (EpoR), or without it (Gata1), as can genes
associated with the “closest”, NK-cell fate (Eomes, Il2rb respectively). In an interesting
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additional case, many multipotent progenitor-cell regulatory genes are expressed throughout
the early stages like Sfpi1 and only shut off during commitment itself. Some may be
sustained by a common progenitor-cell positive regulator, Lmo2 (McCormack et al., 2010),
and our results suggest that many receive input from PU.1 itself. The progenitor-associated
genes may thus constitute a discrete early subcircuit within the T-lineage specification
network.
Finally, our multistage analysis shows that many mouse hematopoietic genes are each likely
controlled by different constellations of cis-regulatory elements at one stage of development
versus another, even within the same cell lineage. In this light, the quest for single, minimal
sufficient regulatory elements for such genes seems naïve, as it would a priori sacrifice the
full range of developmental control. The roles of the candidate cis-elements and their rules
for engagement with promoters should be greatly clarified by future extensions of this
analysis, to detect specific chromatin looping events, enhancer activation states mapped by
association with p300 and H3K4me3, and latent enhancers using H3K4me1 at transcription
factor binding sites. Mechanisms of repression could be clarified when effects on a broader
range of non-activating cis-elements are mapped based on DNase hypersensitivity and DNA
methylation. The mapping of developmentally dynamic histone modification sites provides a
new way to locate the sites in cis-regulatory DNA that process distinct inputs for crucial
regulatory genes. In this collection of regulatory domains lie the answers to how cells are
driven to T-lineage commitment.
METHODS
For full materials and experimental procedures, see Supplement. Briefly, in vitro developing
CD4− CD8− TCR− “double negative” populations were generated from fetal liver
hematopoietic precursors (Taghon et al., 2007) sorted as ETP/DN1 (Kit++ CD44+ CD25−),
“DN2a” (Kit++ CD44+ CD25+), and “DN2b” (Kit+ CD44+ CD25+). “DN3” (Kit− CD44−
CD25+) and “DP” (CD25− CD4+ CD8+) cells were sorted from thymus. ChIP-seq and RNA-
seq were carried out and analyzed as previously reported (Pepke et al., 2009; Mortazavi et
al., 2008; Johnson et al., 2007). The programs ERANGE and DEGSeq were used to compare
samples.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Global comparisons of gene expression among five developmentally related immature
T cell populations
A. Pairwise comparisons in gene expression between successive populations and between
initial FLDN1 vs. final ThyDP stages: statistically changed genes defined by DEGseq (p <
0.001).
B. Hierarchical clustering of expression patterns of all differentially expressed genes
(DEGseq positive, ≥2× changed).
C. Hierarchical clustering of expression patterns of differentially expressed transcription
factors: several key transcription factors indicated.
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Figure 2. Distinct gene expression patterns are associated with characteristic histone
modifications
A. Gene expression and histone modifications at the TSS of 20,861 genes. Expressed (≥
1RPKM) and silent (<1RPKM) genes defined by RNA-seq. Ac: H3Ac, me2: H3K4me2,
me3: H3K27me3.
B. Gene expression and histone modifications at the TSS of 1,646 genes encoding DNA-
binding proteins or transcription factors.
C. Association of promoter-linked histone modifications with developmental change in
expression. Genes are grouped based on histone marks of their TSS in the FLDN2a (top) or
ThyDN3 (bottom) stages: H3Ac− H3K4me2+ (H3K27me3+ or −) in red, H3Ac+
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H3K4me2+ H3K27me3− in blue, H3Ac− H3K4me2− H3K27me3+ in green, and H3Ac−
H3K4me2− H3K27me3− in black. Cumulative distributions of genes in each group are
plotted vs. expression changes from FLDN1 to FLDN2b (top), and from FLDN2b to ThyDP
(bottom). X axis: gene expression change (log2 ratio of RNA-seq levels), downregulated to
the left, upregulated to the right (vertical lines: twofold change). Y axis: fraction of group
with expression change ≤x axis value. P values from Kolmogorov-Smirnov (K–S) two-sided
tests comparing H3Ac−/H3K4me2+ against each of the other three groups are shown.
D. Heatmaps correlating TSS histone modifications with various patterns of
developmentally regulated gene expression for 9 representative expression clusters (from
Fig. S5). Hierarchical clustering within individual clusters used Ward linkage and Euclidean
distance. Histone modification data from EBF−/− pre-pro B cells (H3Ac, H3K4me2 and
H3K27me3; “PPB”) and CD4+ naïve T cells (H3K27me3 only, “CD4”) are also shown for
these genes.
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Figure 3. Histone modifications and gene expression profiles of genes characterizing
hematopoiesis
Results for 379 “hematopoietic” genes are processed and displayed as in Fig. 2D. Master
panel: results for all 379 genes. Panels (a)–(e): zoomed in to indicated cluster regions of
master panel to allow individual genes to be seen.
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Figure 4. Portraits of key T-lineage and alternative-lineage genes
A – H. Distinct epigenetic marking and gene expression patterns at eight different loci:
Bcl11b (A), Cd3e/d/g cluster (B), Gata3 (C), Pax5 (D), Hhex (E), Bcl11a (F), Sfpi1 (G) and
Mpzl2 (H), in all five immature T-populations (top to bottom, DN1, DN2a, DN2b, DN3 and
DP)(coordinates below each panel). Red arrow: TSS and direction of transcription. H3Ac:
blue, H3K4me2: red, H3K27me3: green, RNA-seq: black. Uniform scales are used for
histone marks in all panels, and mRNA scales are uniform within each panel (y axis units in
RPM).
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Figure 5. Lineage specific PU.1 DNA binding is associated with lineage specific histone
modifications and gene expression
A. Mean RNA-seq level of PU.1 (Sfpi1) at each stage of early T-cell development.
B. (Left) Comparisons of PU.1 DNA binding site distributions between FLDN1 and
FLDN2a or FLDN2b, with Pearson’s correlation coefficients (r). (Right) Comparisons of
PU.1 DNA binding-associated H3K4me2 enrichment between FLDN1 and FLDN2a or
FLDN2b. H3K4me2 signal densities were from ±1kb of the summit of a PU.1 bound region.
C. Comparisons of PU.1 DNA binding between FLDN1 and E2A−/− pre-pro B, macrophage
or mature B cells.
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D. Lineage-specific PU.1 binding at the Pax5 locus. B-cell specific Pax5 intronic enhancer
is bound by PU.1 (black arrow) in E2A−/− pre-pro pre-pro B cells (Heinz et al., 2010) (black
track), but not in DN cells (brown tracks). PU.1 ChIP-seq in ThyDP is used as a negative
control. For orientation, H3K4me2 pattern in DN1 stage is included (red track).
E. Lineage specific and shared PU.1 binding sites between FLDN1 and E2A−/− pre-pro B
cells. Lineage specific: ≥4× difference in PU.1 occupancy between populations. Sequence
logos show the most highly enriched sequence motif for each occupancy subgroup.
Percentages of regions from the three subgroups with ≥1 instance of each motif are given in
parentheses beneath each sequence logo (E2A−/− specific/Shared/FLDN1 specific).
F. Distribution of the enrichment of specified histone modification over genomic regions
within ± 1kb of lineage specific and shared PU.1 binding sites in FLDN1 cells.
G. Correlation of mRNA expression levels in FLDN1 with presence of lineage-specific or
shared PU.1 sites. Distribution of mRNA value in FLDN1 for subgroups of genes that are
linked to either E2A−/− pre-pro B specific, FLDN1 specific, or shared PU.1 binding sites,
and genes linked to more than one PU.1 site occupied in FLDN1 cells (Multiple). K-S test
compares E2A−/− Specific Only with each of the other three subgroups (n and p values in
parentheses).
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Figure 6. Functional and stage-dependent PU.1 binding in early T-cell development
A. Stage specific and non stage-specific (shared) PU.1 binding sites: stage specific binding
defined by ≥4× difference in signal densities between FLDN1 and FLDN2b.
B. Differential expression of PU.1 binding linked genes. Top: of 13,335 PU.1 binding linked
genes in DN cells, the numbers expressed in FLDN1 (blue circle) and FLDN2b cells (red
circle) are shown (7,244 stably expressed, 1,045 differentially expressed: ≥2× change). To
test whether PU.1 occupancy correlated with positive or negative regulation, all
differentially expressed genes were split among 3 subgroups based on changes in PU.1
binding to linked sites (see panel A): genes with FLDN1 specific sites only (Loss of PU.1
Zhang et al. Page 23
Cell. Author manuscript; available in PMC 2013 April 13.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
binding in FLDN2b, blue), those retaining PU.1 binding at all sites in FLDN2b (red), and
genes that rapidly lose PU.1 binding from some sites but not others (Mixed, green).
C. Relationship between PU.1 occupancy changes and mRNA expression changes between
FLDN2b and FLDN1: cumulative distributions of expression changes for three groups of
genes depicted in B. The number of genes in each group and p values (K-S tests for
comparisons with “Mixed”) are indicated next to the plots.
D, E. Developmentally distinct PU.1 binding patterns at the Tal1 (D) and Il7ra (E) loci in
FLDN1, FLDN2a, FLDN2b and E2A−/− pre-pro B cells, compared with H3K4me2,
H3K27me3 and mRNA in all five immature T-populations.
F. Distribution of PU.1 occupancy relative to TSS sites in expressed and silent genes at
individual stages.
G. Location of PU.1 sites in potential target genes according to expression pattern. Clusters
of genes with different developmental trajectories (Fig. S5) were scored by the number of
genes they include with PU.1 binding sites ± 1kb from the TSS (proximal) or further from
the TSS (distal). □,◊ (left axis): % of genes in a cluster with proximal (□) or distal (◊) PU.1
binding. Bar graphs (right axis): (number of genes with TSS sites)/(number of genes with
distal sites). Colors of bars relate expression pattern of each cluster to endogenous PU.1
expression (most similar: blue, inverse: red). See Figs. 2D, S5, & Table S6.
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Figure 7. Developmental plasticity of GATA-3 DNA binding and associated epigenetic marking
A – D. Stage-specific GATA-3 binding (brown) in Lyl1, Ets2-Erg, Itk and Tcfe2a loci of
FLDN1, FLDN2b and ThyDP cells, shown with binding associated H3K4me2 (red) and
H3K27me3 (green) enrichment and mRNA (black) expression in all five immature T-
populations.
E. Cumulative distributions of changes in GATA-3 occupancy between FLDN2b and
FLDN1 (top) and between ThyDP and FLDN2b (bottom), for genes differentially regulated
across the same intervals. GATA-3 binding sites were divided into 4 subgroups, based on
linkage to downregulated genes (blue), upregulated genes (red), stably expressed genes (< 2-
fold change in expression, green) and silent gene sites (<1RPKM in both stages, black). P
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values are from K-S tests between stably expressed gene sites and each of the other three
subgroups (n= no. of sites).
F. Cumulative distributions of changes in H3K4me2 marks associated with GATA-3
binding between FLDN2b and FLDN1 (top) and between ThyDP and FLDN2b (bottom)
stages. H3K4me2 signal densities were calculated within −/+1kb of the summit of a given
GATA-3 bound region (depicted in Figure 7H). P values calculated as in E.
G. Most highly enriched sequence motifs in GATA-3 binding regions (see panel H). The
percentages of regions containing ≥1 instance of each motif are indicated beneath each
sequence logo, with the expected frequency of the motif in random regions in parentheses.
H. Scatter plots depicting the comparisons in GATA-3 binding between FLDN1, FLDN2b
and ThyDP. Pearson correlation coefficients are shown for each comparison.
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